99074328 - DYNAMICURE

Information

• Trademark
• 99074328

• Source

• Serial Number

  99074328

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 08, 2025
  a year ago

• Transaction Date

  July 10, 2025
  10 months ago

• Status Date

  March 08, 2025
  a year ago

• Status Code

  630

• Attorney Docket Number

  131743-00401

  Attorney Name

  Keith Toms

• Owners

  • DynamiCure Biotechnology, LLC

Case File Statements

• DM0000: The mark consists of an image of a wild boar to the left of the word "DYNAMICURE".
• GS0051: Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders, autoimmune deficiency; Pharmaceutical preparations for the treatment of genetic disorders; Pharmaceutical preparations for the treatment of metabolic diseases; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of eye diseases; Pharmaceutical preparations for the treatment of cardiovascular diseases; Diagnostic biomarker reagents for medical purposes; Protein arrays for medical diagnosis purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment of oncological diseases and disorders, autoimmune diseases and disorders, autoimmune deficiency, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, cardiovascular diseases, all of the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases
• GS0421: Pharmaceutical research and development; Research and development in the field of biologics, namely, antibodies and peptides for the field of cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, and cardiovascular diseases; Research and development in the field of pharmaceuticals, biopharmaceuticals, and biotechnologies for the treatment of cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, and cardiovascular diseases; Research and development in the field of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics in the field of cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases eye diseases, and cardiovascular diseases; Providing medical and scientific research information; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmacogenetics; Research and development in the field of oncological diseases and disorders, autoimmune diseases and disorders, autoimmune deficiency, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, cardiovascular diseases, all of the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases

Case File Event Statements

• 3/8/2025 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 3/8/2025 - a year ago

  2 - APPLICATION FILING RECEIPT MAILED Type: MAFR